documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
7 rows where docket_id = "FDA-2005-N-0021" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
agency_id 1
- FDA 7
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0021-0009 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Letter to Symrise, Inc from FDA CDER | Other | Letter(s) | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T05:00:00Z | 2020-11-02T17:43:09Z | 0 | 0 | 09000064849469b9 | ||
| FDA-2005-N-0021-0008 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Climbazole TEA Letter to Representatives of Symrise Inc. and Proctor and Gamble | Other | Letter(s) | 2020-01-14T05:00:00Z | 2020 | 1 | 2020-01-14T05:00:00Z | 2020-01-14T16:13:20Z | 0 | 0 | 09000064842a002e | ||
| FDA-2005-N-0021-0007 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Letter from FDA CDER to Representatives of Symrise Inc. re: Climbazole TEA and Proctor & Gamble | Other | Letter(s) | 2019-08-29T04:00:00Z | 2019 | 8 | 2019-08-29T04:00:00Z | 2020-10-29T12:59:54Z | 0 | 0 | 0900006483ed9393 | ||
| FDA-2005-N-0021-0006 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Feedback Letter from FDA CDER to Steinberg & Associates Inc. | Other | Letter(s) | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T05:00:00Z | 2018-12-21T13:41:05Z | 0 | 0 | 09000064839bd85a | ||
| FDA-2005-N-0021-0005 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Letter from Steinberg & Associates, Inc. to FDA | Other | Letter(s) | 2009-02-20T05:00:00Z | 2009 | 2 | 2005-12-05T05:00:00Z | 2006-03-07T04:59:59Z | 2020-10-29T12:27:32Z | 0 | 0 | 090000648085fbd4 | |
| FDA-2005-N-0021-0004 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Procter & Gamble Company [Climbazole] Safety and Efficacy Review - Supplement | Other | SUP-Supplement | 2008-07-15T04:00:00Z | 2008 | 7 | 2008-07-15T04:00:00Z | 2020-10-29T12:28:41Z | 0 | 0 | 090000648063da87 | ||
| FDA-2005-N-0021-0001 | FDA | Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Dandruff Control Ingredient | Notice | NRD-Notice of Requesting Data, Info, & Views | 2005-12-05T05:00:00Z | 2005 | 12 | 2005-12-05T05:00:00Z | 2006-03-07T04:59:59Z | 2020-10-29T12:03:48Z | 0 | 0 | 090000648043e759 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);